Waggoner, Steven
https://orcid.org/0000-0001-7037-4858
Mayo Clinic
University Hospitals of Cleveland
Citations 2
Single-Arm Phases 1 and 2 Trial of Niraparib in Combination With Pembrolizumab in Patients With Recurrent Platinum-Resistant Ovarian Carcinoma
Konstantinopoulos, Panagiotis A. , Waggoner, Steven , Vidal, Gregory A. , Mita, Monica , Moroney, John W. , Holloway, Robert W. , Le, Linda Van, Sachdev, Jasgit C. , Chapman‐Davis, Eloise , Colón‐Otero, Gerardo , Penson, Richard T. , Matulonis, Ursula A. , Kim, Young Bae , Moore, Kathleen N. , Swisher, Elizabeth M. , D’Andrea, Alan D. , Stringer-Reasor, Erica , Wang, Jing , Buerstatte, Nathan, Arora, Sujata, Graham, Julie R. , Bobilev, Dmitri, Dezube, Bruce J., Swisher, Elizabeth M , Moore, Kathleen , Konstantinopoulos, Panagiotis A , D'Andrea, Alan , Färkkilä, Anniina , Münster, Pamela N.
JAMA Oncology | June 13, 2019 | Volume: 5 | Issue: 8 | Pages: 1141
TOPACIO/Keynote-162 (NCT02657889): A phase 1/2 study of niraparib + pembrolizumab in patients (pts) with advanced triple-negative breast cancer or recurrent ovarian cancer (ROC)—Results from ROC cohort.
Konstantinopoulos, Panagiotis A. , Waggoner, Steven , Vidal, Gregory A. , Mita, Monica , Holloway, Robert W. , Le, Linda Van, Sachdev, Jasgit C. , Chapman‐Davis, Eloise , Colón‐Otero, Gerardo , Penson, Richard T. , Matulonis, Ursula A. , Kim, Young B., Dezube, Bruce J., Wang, Jing Y., Buerstatte, Nathan, Arora, Sujata, Münster, Pamela N. , Munster, Pamela , Konstantinopoulos, Panagiotis A , Fleming, Gini F. , Moore, Kathleen N. , Swisher, Elizabeth M.
Journal of Clinical Oncology | September 5, 2018 | Volume: 36 | Issue: 15_suppl | Pages: 106-106